PCRX vs. FFIV
PCRX (Pacira BioSciences, Inc.) and FFIV (F5 Networks, Inc.) are both stocks. PCRX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while FFIV operates in Software - Infrastructure (Technology). Over the past 10 years, PCRX returned -7.19%/yr vs 13.92%/yr for FFIV. At a 0.22 correlation, their price movements are largely independent.
Performance
PCRX vs. FFIV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PCRX achieves a -13.76% return, which is significantly lower than FFIV's 58.92% return. Over the past 10 years, PCRX has underperformed FFIV with an annualized return of -7.19%, while FFIV has yielded a comparatively higher 13.92% annualized return.
PCRX
- 1D
- 0.31%
- 1M
- -9.60%
- YTD
- -13.76%
- 6M
- -7.73%
- 1Y
- -15.45%
- 3Y*
- -17.04%
- 5Y*
- -18.20%
- 10Y*
- -7.19%
FFIV
- 1D
- -0.85%
- 1M
- 22.95%
- YTD
- 58.92%
- 6M
- 68.58%
- 1Y
- 39.57%
- 3Y*
- 40.34%
- 5Y*
- 16.53%
- 10Y*
- 13.92%
PCRX vs. FFIV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | -13.76% | 37.37% | -44.16% | -12.61% | -35.83% | 0.55% | 32.10% | 5.30% | -5.76% | 41.33% |
FFIV F5 Networks, Inc. | 58.92% | 1.51% | 40.50% | 24.72% | -41.36% | 39.09% | 25.99% | -13.81% | 23.48% | -9.33% |
Correlation
The correlation between PCRX and FFIV is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2011 | 0.22 |
The correlation between PCRX and FFIV shifts across timeframes, from -0.01 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PCRX:
$913.11M
FFIV:
$23.24B
PCRX:
$0.21
FFIV:
$12.19
PCRX:
104.26
FFIV:
33.28
PCRX:
1.32
FFIV:
9.77
PCRX:
1.40
FFIV:
6.37
PCRX:
$734.86M
FFIV:
$2.41B
PCRX:
$427.72M
FFIV:
$2.63B
PCRX:
$95.04M
FFIV:
$889.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCRX vs. FFIV — Risk / Return Rank
PCRX
FFIV
PCRX vs. FFIV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacira BioSciences, Inc. (PCRX) and F5 Networks, Inc. (FFIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PCRX | FFIV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.62 | ||
| Sortino ratioReturn per unit of downside risk | -2.08 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.23 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.52 | 1.14 | -1.67 |
| Martin ratioReturn relative to average drawdown | -1.07 | 2.52 | -3.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PCRX | FFIV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.42 | 1.20 | -1.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.40 | 0.55 | -0.96 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.15 | 0.47 | -0.62 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.27 | -0.12 |
Drawdowns
PCRX vs. FFIV - Drawdown Comparison
The maximum PCRX drawdown since its inception was -90.19%, smaller than the maximum FFIV drawdown of -97.59%. Use the drawdown chart below to compare losses from any high point for PCRX and FFIV.
Loading charts...
Drawdown Indicators
| PCRX | FFIV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.19% | -97.59% | +7.40% |
Max Drawdown (1Y)Largest decline over 1 year | -29.61% | -34.73% | +5.12% |
Max Drawdown (3Y)Largest decline over 3 years | -71.53% | -34.73% | -36.80% |
Max Drawdown (5Y)Largest decline over 5 years | -85.67% | -47.42% | -38.25% |
Max Drawdown (10Y)Largest decline over 10 years | -85.67% | -54.59% | -31.08% |
Current DrawdownCurrent decline from peak | -81.29% | -0.85% | -80.44% |
Average DrawdownAverage peak-to-trough decline | -50.01% | -40.21% | -9.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.42% | 15.76% | -1.34% |
Volatility
PCRX vs. FFIV - Volatility Comparison
Pacira BioSciences, Inc. (PCRX) has a higher volatility of 10.03% compared to F5 Networks, Inc. (FFIV) at 8.06%. This indicates that PCRX's price experiences larger fluctuations and is considered to be riskier than FFIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PCRX | FFIV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.03% | 8.06% | +1.97% |
Volatility (6M)Calculated over the trailing 6-month period | 28.70% | 24.62% | +4.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.03% | 33.26% | +3.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.60% | 29.99% | +15.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.90% | 29.82% | +17.08% |
Dividends
PCRX vs. FFIV - Dividend Comparison
Neither PCRX nor FFIV has paid dividends to shareholders.
Financials
PCRX vs. FFIV - Financials Comparison
This section allows you to compare key financial metrics between Pacira BioSciences, Inc. and F5 Networks, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PCRX and FFIV have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PCRX has higher volatility (10.03%) compared to FFIV (8.06%). In terms of maximum drawdown, PCRX dropped -90.19% vs FFIV's -97.59%.
FFIV currently has the higher Sharpe Ratio (1.20 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PCRX and FFIV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer